Total Payments
$381.98
2022 Payments
$23.11
Companies
6
Transactions
21
Medicare Patients
5,269
Medicare Billing
$479,718
Payment Breakdown by Category
Food & Beverage$352.98 (92.4%)
Education$29.00 (7.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $352.98 | 19 | 92.4% |
| Education | $29.00 | 2 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $116.24 | 6 | $0 (2022) |
| PFIZER INC. | $87.27 | 6 | $0 (2019) |
| AbbVie, Inc. | $70.41 | 4 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $53.83 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $29.00 | 2 | $0 (2018) |
| Nestle HealthCare Nutrition Inc. | $25.23 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $23.11 | 1 | Janssen Biotech, Inc. ($23.11) |
| 2021 | $46.51 | 3 | Nestle HealthCare Nutrition Inc. ($25.23) |
| 2020 | $71.85 | 4 | Janssen Biotech, Inc. ($71.85) |
| 2019 | $145.81 | 7 | PFIZER INC. ($67.96) |
| 2018 | $94.70 | 6 | AbbVie, Inc. ($46.39) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/10/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Immunology | ||||||
| 08/27/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/12/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/27/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Immunology | ||||||
| 11/10/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Immunology | ||||||
| 09/15/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Immunology | ||||||
| 07/23/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Immunology | ||||||
| 06/16/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Immunology | ||||||
| 06/21/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/19/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $53.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/14/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/16/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/13/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 03/12/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/25/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/20/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology | ||||||
| 11/15/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Immunology | ||||||
| 10/04/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Immunology | ||||||
| 09/28/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/30/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 05/30/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,173 | 1,198 | $898,172 | $116,184 |
| 2022 | 10 | 1,146 | 1,174 | $988,363 | $107,513 |
| 2021 | 13 | 1,315 | 1,379 | $1.1M | $122,828 |
| 2020 | 11 | 1,635 | 1,715 | $1.3M | $133,193 |
Total Patients
5,269
Total Services
5,466
Medicare Billing
$479,718
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 133 | 133 | $147,896 | $22,996 | 15.5% |
| 44361 | Biopsy of small bowel (except ileum) using an endoscope | Facility | 2023 | 304 | 315 | $115,290 | $21,227 | 18.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 197 | 207 | $175,122 | $20,488 | 11.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 206 | 207 | $203,895 | $19,194 | 9.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 67 | 67 | $55,409 | $11,697 | 21.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 48 | 48 | $39,696 | $8,174 | 20.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 55 | 55 | $45,485 | $6,352 | 14.0% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 12 | 12 | $10,692 | $2,864 | 26.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 53 | 55 | $45,045 | $2,336 | 5.2% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 55 | 55 | $54,450 | $682.70 | 1.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 43 | 44 | $5,192 | $171.89 | 3.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 222 | 222 | $218,670 | $22,921 | 10.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 116 | 116 | $128,992 | $20,799 | 16.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 170 | 174 | $147,204 | $17,598 | 12.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 355 | 373 | $305,487 | $16,520 | 5.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 64 | 64 | $52,928 | $11,381 | 21.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 45 | 45 | $37,215 | $7,848 | 21.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 62 | 63 | $52,101 | $7,626 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,524 | $2,183 | 29.0% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $30,690 | $375.38 | 1.2% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 59 | 64 | $7,552 | $261.21 | 3.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 240 | 259 | $219,114 | $27,654 | 12.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 263 | 263 | $259,055 | $27,261 | 10.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 118 | 118 | $131,216 | $22,674 | 17.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 416 | 447 | $366,093 | $18,372 | 5.0% |
About Dr. Stephen Kirkpatrick, M.D
Dr. Stephen Kirkpatrick, M.D is a Gastroenterology healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588619787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Kirkpatrick, M.D has received a total of $381.98 in payments from pharmaceutical and medical device companies, with $23.11 received in 2022. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($352.98).
As a Medicare-enrolled provider, Kirkpatrick has provided services to 5,269 Medicare beneficiaries, totaling 5,466 services with total Medicare billing of $479,718. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Bartlesville, OK
- Active Since 05/24/2006
- Last Updated 11/07/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1588619787
Products in Payments
- STELARA (Biological) $116.24
- XELJANZ (Drug) $87.27
- Humira (Biological) $70.41
- XIFAXAN (Drug) $53.83
- Kanuma (Drug) $29.00
- ZENPEP (Drug) $25.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.